Neumora Therapeutics is trading at $0.50, up 5.53% after hours, with no clear catalyst identified.
- Available news listings show no fresh company-specific announcement tied to the October 16 move; recent releases are older.
- Shares rose 10.96% in the October 16 regular session, after gaining 20.45% on October 15.
- Broader indexes fell October 16; available evidence does not show the after-hours rise tracking the wider market. No after-hours volume data was provided.